Why Lexapro Causes Insomnia and How to Manage It

Lexapro (escitalopram) commonly causes insomnia, particularly during the first weeks of treatment. In clinical trials, the drug raises the odds of insomnia compared to placebo, and sleep disruption ranks among its most frequently reported side effects. What makes the picture more complicated is that Lexapro can also improve sleep over time, since the depression and anxiety it treats are themselves major drivers of poor sleep. Whether you end up sleeping worse, sleeping better, or cycling through both depends on timing, dose, and what your sleep looked like before you started.

How Common Is Lexapro-Related Insomnia

The reported rates vary depending on the study and what condition is being treated. A large network meta-analysis of 21 antidepressants found that escitalopram roughly tripled the odds of somnolence (excessive sleepiness) compared to placebo and raised the odds of insomnia by about 37%, translating to roughly 19 extra cases of insomnia per 1,000 patients treated during acute-phase treatment for major depression.¹ Those numbers reflect controlled trial conditions and a depression population.

In a trial of escitalopram for anxiety disorders, the insomnia rate was strikingly higher. Among people taking the drug, 41% reported insomnia or sleep disturbance as an adverse event, making it the single most common side effect, ahead of nausea and fatigue.² That number is considerably higher than what depression trials typically show, which suggests the underlying condition matters. People with anxiety disorders may be more vulnerable to the activating effects of SSRIs, or the way insomnia is defined and captured in each study may differ. Either way, the insomnia risk with escitalopram is real and common, though it is broadly similar to other SSRIs and somewhat lower than what you’d see with SNRIs like venlafaxine or duloxetine.³

How Lexapro Can Disrupt Sleep and Improve It at the Same Time

One of the confusing things about Lexapro and sleep is that you will find data showing it causes insomnia alongside data showing it helps with sleep problems. Both are true, and they are not contradictory once you consider the timeline.

In pooled data from randomized trials of depressed patients, escitalopram significantly improved scores on the specific sleep-disturbance item of a standard depression rating scale by weeks six and eight, outperforming both placebo and citalopram (the older version of the molecule).⁴ This makes sense: depression itself causes terrible sleep, and as the drug lifts the depression, sleep gets better along with it. The insomnia that shows up as a side effect, by contrast, tends to cluster in the first days to weeks, when serotonin levels are shifting but mood has not yet caught up. So the drug can make sleep worse in the short run while making it better in the long run, with the net result depending on where you are in that timeline.

If your insomnia existed before you started Lexapro and was driven by depression, there is a reasonable chance the drug will eventually help. If you were sleeping fine and insomnia appeared only after starting the medication, the drug is more likely the direct cause.

What Serotonin Does to Sleep Architecture

To understand why Lexapro causes insomnia, it helps to know that serotonin is not simply a “feel good” chemical. It plays a direct and complex role in sleep regulation. Boosting serotonin, which is exactly what Lexapro does, tends to suppress REM sleep. In animal studies, escitalopram significantly reduced the time spent in REM and increased REM latency (the time it takes to enter REM after falling asleep), while also increasing slow-wave sleep, the deep restorative stage.⁵ This trade-off, less REM but more deep sleep, is a hallmark of SSRI effects on sleep.

Serotonin receptors come in many subtypes, and they don’t all do the same thing. The 5-HT2C receptor is especially relevant to sleep. Research on chronic escitalopram use found that adaptation at this receptor subtype happened unevenly: REM suppression adapted over time, but other effects on wakefulness and brain-wave activity did not.⁶ In plain terms, some aspects of sleep disruption fade as your brain adjusts to the new serotonin levels, while others linger. This helps explain why some people’s insomnia resolves after a few weeks and others’ persists.

Melatonin and Your Body Clock

A separate piece of the puzzle involves melatonin. People with major depression often have abnormal melatonin rhythms to begin with, including lower levels overall and a delayed peak. In healthy individuals, melatonin peaks around 3 AM. In depressed patients studied before and after eight weeks of escitalopram treatment, that peak was delayed by about three hours, hitting around 6 AM instead. Escitalopram did not correct this delay, and it did not restore the reduced melatonin levels either.⁷

A broader look at circadian biology confirmed this picture. Depression disrupts the daily rhythms of multiple clock genes and hormones, and several of those disruptions, including melatonin and cortisol rhythms, persisted even after eight weeks of escitalopram treatment and clinical improvement in mood.⁸ This is a meaningful finding: it means that even when Lexapro is working well for your mood, your internal clock may still be out of sync. For someone whose insomnia is rooted more in circadian disruption than in serotonin activation, the drug alone may not be enough to fix sleep.

Why Dose Matters

The relationship between Lexapro dose and insomnia is not a straight line up. The large network meta-analysis that compared 21 antidepressants found that for escitalopram, the risk of insomnia stayed relatively flat at low and moderate doses, then climbed at higher doses.⁹ Sleepiness, interestingly, followed a different pattern: it gradually increased from low to moderate doses and then decreased at higher doses.

What this means practically is that if you’re experiencing insomnia at a lower dose, bumping up might not make it much worse. But if you’re at the higher end of the dosing range (around 20 mg), the insomnia risk is more pronounced. If sleep problems are severe, your prescriber might consider whether the therapeutic benefit at a high dose justifies the sleep cost, or whether a slightly lower dose would preserve the mood benefit with less nighttime disruption.

How Lexapro Stacks Up Against Other Antidepressants

Within the large family of antidepressants, Lexapro falls in the middle of the pack for insomnia risk. Eleven antidepressants had significantly higher odds of insomnia than placebo in the network meta-analysis, with reboxetine at the top and escitalopram near the bottom of that list. For context, the odds ratios for insomnia ranged from 3.47 for reboxetine down to 1.37 for escitalopram.¹⁰ So while Lexapro does increase insomnia risk, it does so less aggressively than vilazodone, desvenlafaxine, duloxetine, bupropion, venlafaxine, sertraline, citalopram, fluoxetine, or paroxetine.

On the other end, escitalopram is more likely to cause sleepiness than insomnia. Its somnolence odds ratio of 2.87 was notably higher than its insomnia odds ratio of 1.37. This means some people on Lexapro will feel excessively drowsy rather than unable to sleep, and a minority will experience both at different times of day, drowsy in the morning and wired at night. The dual nature of these effects is one reason responses vary so much from person to person.

Some antidepressants, like mirtazapine and trazodone, are strongly sedating and much more likely to cause sleepiness than insomnia. They are sometimes used specifically because of this profile. Agomelatine, which acts directly on melatonin receptors, had the lowest insomnia signal in the analysis. If insomnia is a dealbreaker on Lexapro, these alternatives are worth discussing with your provider, though each comes with its own trade-offs.

Practical Strategies for Managing Lexapro Insomnia

If you’re dealing with insomnia after starting Lexapro, there are several approaches worth considering, roughly in order of how commonly they’re tried.

Wait it out: For many people, the insomnia is worst in the first one to three weeks and gradually fades as the brain adjusts to higher serotonin levels. If the insomnia is tolerable and your mood is improving, giving it a few more weeks is often reasonable.
Shift the timing: Taking your dose in the morning rather than at night can help if the drug’s activating effects peak a few hours after you swallow it. This is a simple change with no downside for most people.
Add a low-dose sleep aid: Trazodone, a sedating antidepressant used at low doses, has been shown to be effective for insomnia caused by activating antidepressants.¹¹ It’s one of the most common add-on prescriptions in this situation. Newer options like orexin receptor antagonists (suvorexant and daridorexant) have also shown promise for insomnia in people with depression, with evidence that they can improve both sleep and mood symptoms simultaneously.¹²
Address sleep hygiene: This sounds generic, but it matters more when a medication is pushing you toward wakefulness. A dark, cool room, consistent wake times, and limiting screen exposure at night can shift the balance enough to make the insomnia manageable.
Consider a dose adjustment: Since insomnia risk tends to be higher at the top of the dose range, dropping from 20 mg to 15 mg or 10 mg, if clinically appropriate, may help.

These strategies are not mutually exclusive. A common real-world approach involves taking Lexapro in the morning, adding low-dose trazodone at bedtime during the first month or two, and then tapering the trazodone once the initial sleep disruption settles.

Sleep Disruption When You Stop Lexapro

Insomnia can also appear, or reappear, when you discontinue Lexapro. Sleep disturbance is among the recognized withdrawal effects of stopping antidepressants, alongside dizziness, headache, and mood swings.¹³ These symptoms are typically mild and self-limiting, but they can be alarming if you don’t expect them. Vivid dreams and disrupted sleep are particularly common during SSRI withdrawal, likely because REM sleep, which had been suppressed by the drug, rebounds aggressively once serotonin levels drop.

Tapering slowly rather than stopping abruptly reduces the severity of these effects. If you experienced insomnia when you first started Lexapro, you may be more likely to experience sleep disruption during discontinuation as well, though the mechanism is different. Startup insomnia comes from a sudden increase in serotonin activity; withdrawal insomnia comes from the abrupt removal of it.

Lexapro and Insomnia in Children and Adolescents

Younger patients have their own risk profile. A recent meta-analysis of newer-generation antidepressants in children and adolescents with major depression found a modest but significant increase in the odds of insomnia compared to placebo. The finding held across SSRIs and SNRIs without a clear difference between the two classes.¹⁴ The analysis also found that insomnia risk was higher when antidepressants were used for anxiety disorders and OCD than for depression in this age group.

That last finding echoes the adult data, where the anxiety trial reported a much higher insomnia rate than depression trials. The pattern suggests something about the interaction between SSRI activation and an already-hyperaroused nervous system. Anxious brains may be more sensitive to the wakefulness-promoting effects of serotonin, regardless of age. For parents of children starting Lexapro, monitoring sleep in the first few weeks is especially important, and the same timing strategies that help adults (morning dosing, consistent bedtime routines) apply.

The Circadian Angle and Why Melatonin Supplements Come Up So Often

Given that escitalopram doesn’t correct the melatonin disruptions seen in depression, it’s no surprise that melatonin supplements are frequently discussed in online patient communities as a remedy for Lexapro insomnia. The logic seems straightforward: if the drug doesn’t restore normal melatonin rhythms, maybe taking melatonin externally will fill the gap. While the research on exogenous melatonin for antidepressant-related insomnia specifically is limited, the circadian data provides a plausible rationale. The delayed peak and reduced amplitude of melatonin seen in depressed patients, which persisted despite escitalopram treatment, represent a real physiological gap that the drug leaves unaddressed.¹⁵

This is also part of why agomelatine, an antidepressant that directly targets melatonin receptors alongside serotonin receptors, showed the lowest insomnia signal in the large comparative meta-analysis. It addresses both the mood pathway and the circadian pathway simultaneously. For people on Lexapro who find that sleep problems persist well past the initial adjustment period, the lingering circadian misalignment may be part of the reason. Bringing this up with a prescriber can open a conversation about whether melatonin supplementation, light therapy, or a medication switch could help.

When Insomnia Might Mean the Medication Isn’t the Right Fit

Most discussions of Lexapro insomnia focus on management, and reasonably so, because it’s often a temporary side effect that resolves or can be worked around. But persistent, severe insomnia that doesn’t improve after four to six weeks, doesn’t respond to timing changes or add-on sleep aids, and actively undermines your daily functioning is worth treating as a signal rather than just a nuisance. Sleep deprivation itself worsens depression and anxiety, creating a cycle where the treatment intended to help your mood is indirectly harming it through sleep loss.

The comparative data makes clear that not all antidepressants affect sleep the same way. Escitalopram’s insomnia odds are on the lower end among SSRIs, but they still exist. If the insomnia profile is unacceptable and your mood responded well to Lexapro, switching to a closely related SSRI with a slightly different receptor profile, or to an antidepressant with a sedating profile like mirtazapine, may preserve the mood benefit while resolving the sleep problem. These are decisions that depend on the full clinical picture, but knowing that alternatives exist and that persistent insomnia is a legitimate reason to explore them is useful information to bring to an appointment.